I think I played there this weekend as well.
He seems to be exhibiting the early stages of Alzheimer's right before our eyes. Irrational, irritable, confused. But alas he has found purpose in his life here on the yahoo message boards. I'm sure somewhere right now there is a team sculptors trying to figure out which head on Mt. Rushmore can be converted into his likeness. A true legacy.
rkf, it would appear that some are sensitive to what is the truth. Regressives? The only elected democrat in Arizona is vehemently opposing the right to try legislation. He is on the only one. The rest of the sponsorship looks like this:
The measure was primarily sponsored by Rep. Phil Lovas (R-22), Rep. John Allen (R-15), Rep. Sonny Borrelli (R-5), Rep. Paul Boyer (R-20), Rep. Tom Forese (R-17), Rep. Adam Kwasman (R-11), Rep. David Livingston (R-22), Rep. Ethan Orr (R-9), Rep Lisa Otondo (D-4) and Rep. Carl Seel (R-20) in the House, where it was known as House Concurrent Resolution 2005. The approved resolution was filed with the Arizona Secretary of State on April 16, 2014.
Kempler should produce a letter to shareholders and get everyone on the same page.
Must "coincidence" that the states pushing for Right to Try are mainly red states. Arizona, Missouri, Louisiana, Colorado. Colorado being a blended exception.
Robin William's would have to move out of the Democrat infested state of California to have a chance at using a drug before it was approved by the FDA.
Perhaps if PBT434 was on the market he would still be walking around.
Maybe Prana should focus on easier market entries for PBT2. Like Australia, China, or pretty much anywhere that isn't the United States. I'll get my pilots license and become the next George Jung.
You need to convert your shares to the ADR symbol AVMXY. Avita had BNY Mellon do it free for those willing. I had mine converted. The future of Avita will revolve around the AVMXY shares.
The idea of dilution doesn't bother me, though I do not wish to see another round of it timed like the last one. The outstanding shares are low, especially for a biotech. I don't start to get turned off until they get close to 100 million shares outstanding and we are so far from that point I don't even think about it.
As has been said many times on this board Prana will go for a Phase III HD trial first and that is within their ability to handle by themselves. But that is not justification for letting AD sit. Even if they had 200mm in the bank their people could not handle both trials at the same time while developing PBT434, 519, and whatever else. I would like to see Prana find a partner for AD. The interest is there. The terms might not be what Kempler wants but they will likely be a fair compromise. I want to see Prana make a deal with a company that is willing to put up the money and man power needed to conduct a real trial and support PBT2 for AD the way it so obviously needs. Get the the drug onto the market ASAP so you can help sick people and rake in cash while the patent life is still there or before other viable options are created by competing companies.
I find Seeking Alpha to be a useful place for open source writing but I look at more stocks than just PRAN. It's funny to me when someone uses a message board like this but doesn't care for Seeking Alpha because they are very similar in how they operate. I believe Yahoo began to view SA as a threat to Yahoo Finance, and they should. Whatever Yahoo plans to do to substitute, perhaps add their own content etc, they will probably fail miserably at.
Kempler should issue a letter to shareholders so everyone can get on the same page.